1 |
Report of the review of NHS pathology services in England. An independent review for the Department of Health. London: Department of Health, 2006.
|
2 |
Hallworth MJ. The ‘70% claim’: what is the evidence base?[J] Ann Clin Biochem, 2011, 48:487-488.
|
3 |
The Lewin Group, Inc. Laboratory medicine: a national status report.Falls Church,VA: The Lewin Group, Inc; 2008.
|
4 |
MaRS Discovery District. Life sciences: Molecular diagnostics.New tools for evidence-based medicine[N/OL]. 2009[2009-09-14].http://www.marsdd.com/wp- content/uploads/2011/ 02/MaRSReport-Molecular-Diagnostics.pdf.
|
5 |
Billings P. Three barriers to innovative diagnostics[J]. Nat Biotechnol,2006,24: 917-918.
|
6 |
Dillon K, Prokesch S. Megatrends in global health care[N/OL]. http://hbr.org/web/extras/insight-center/health-care/globaltrends/Accessed 14 September 2013.
|
7 |
Fraser CG. Biological variation: from principles to practice.2001:151pp AACC Press Washington, DC. 2011.
|
8 |
The International Organization for Standardization. ISO 15189-2012: Medical laboratories-particular requirements for quality and competence. 2012.
|
9 |
Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine[J].Clin Chem, 2002, 48: 691-698.
|
10 |
Beastall GH. Adding value to laboratory medicine: a professional responsibility[J]. Clin Chem Lab Med, 2013,51:221-228.
|
11 |
McLawhon RW. Patient safety and clinical effectiveness as imperatives for achieving harmonization inside and outside the laboratory[J]. Clin Chem[J], 2011,57:936-938.
|
12 |
Magdal U, Dybkaer R, Olesen H. Properties and units in the clinical laboratory sciences, Part XXIII. The NPU terminology, principles and implementation-a user′s guide[J]. Clin Chem Lab Med, 2012,50:35-50.
|
13 |
Tate JR, Johnson R, Legg M. Harmonisation of laboratory testing[J].Clin Biochem Rev, 2012,33:81-84.
|
14 |
The International Organization for Standardization. ISO 17511:2003.In vitro diagnostic medical devices. Measurement of quantities in biological samples. Metrological traceability of values assigned to calibrators and control materials. 2003.
|
15 |
Barth JH. Selecting clinical quality indicators in laboratory medicine[J].Ann Clin Biochem, 2012,49:257-261.
|
16 |
Barlow IM. Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey[J]. Ann Clin Biochem, 2008,45:88-90.
|
17 |
Genzen JR, Tormey CA. Pathology consultation on reporting critical of values[J]. Am J Clin Pathol, 2011,135:505-513.
|
18 |
Verbocket-van de Venne WP, AAkre KM, Watine J, et al. Reflective testing: adding value to laboratory testing[J]. Clin Chem Lab Med,2012,50:1249-1252.
|
19 |
Li P, Challand GS. Experience with assessing the quality of comments on clinical biochemistry reports[J]. Ann Clin Biochem, 1999,36:759-765.
|
20 |
Linnet K, Bossuyt PM, Moons KG, et al. Quantifying the accuracy of a diagnostic test or marker[J]. Clin Chem, 2012,58:1292-1301.
|
21 |
Beastall GH. The modernisation of pathology and laboratory medicine in the UK. Networking into the future[J]. Clin Biochem Rev,2008,29:3-10.
|
22 |
Madabhushi A, Doyle S, Lee G, et al. Integrated diagnostics: a conceptual framework with examples[J]. Clin Chem Lab Med,2010,48:989-998.
|
23 |
Price CP. Evidence-based laboratory medicine: is it working in practice?[J] Clin Biochem Rev, 2012,33:13-19.
|
24 |
Oosterhuis WP, Bruns DE, Watine J, et al. Evidence-based guidelines in laboratory medicine: Principles and methods[J]. Clin Chem,2004,50:806-818.
|
25 |
Hood L, Friend SH. Predictive, personalised, preventive, participatory(P4) cancer medicine[J]. Nat Rev Clin Oncol, 2011,8:184-187.
|
26 |
Agarwal A. Do companion diagnostics make economic sense for drug developers?[J] N Biotechnol, 2012,29:695-708.
|
27 |
Novis DA, Konstantakos G. Reducing errors in the practices of pathology and laboratory medicine. An industrial approach[J]. Am J Clin Path, 2006,126 Suppl 1: S30-35.
|
28 |
Smellie WS. Demand management and test request rationalization[J].Ann Clin Biochem, 2012,49(Pt 4):323-336.
|
29 |
Thomas RE, Croal BL, Ramsay C, et al. Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial[J]. Lancet, 2006,367:1990-1996.
|
30 |
Price CP, Jones RG. The challenges in commissioning laboratory medicine(pathology) services[J]. J Manage Market Health, 2008,1:166-178.
|
31 |
Anonychuk A, Beastall G, Shorter S, et al. A framew1ork for assessing the value of laboratory diagnostics. Health Care Managem Forum,2012,25:S4-S11.
|
32 |
Lee DW, Neumann PJ, Rizzo JA. Understanding the medical and nonmedical value of diagnostic testing[J]. Val Health, 2010,13:310-314.
|